Connection

Cristina Gervasoni to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Cristina Gervasoni has written about Drug Administration Schedule.
Cristina Gervasoni
Connection Strength
0.324
Drug Administration Schedule
  1. Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor. Eur J Drug Metab Pharmacokinet. 2019 Jun; 44(3):319-327.
    View in: PubMed
    Score: 0.117
  2. Pregnancy-related changes of antiretroviral pharmacokinetics: an argument for therapeutic drug monitoring. Antivir Ther. 2017; 22(4):361-363.
    View in: PubMed
    Score: 0.099
  3. Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect? Antivir Ther. 2017; 22(4):353-356.
    View in: PubMed
    Score: 0.099
  4. Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study. Arch Intern Med. 2002 Dec 9-23; 162(22):2621-8.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.